What this instrument does
The National Health (Efficient Funding of Chemotherapy) Special Arrangement Amendment (June Update) Instrument 2026 makes a technical amendment to the rules that govern how chemotherapy drugs are funded under a special arrangement with the federal government.
The instrument amends the National Health (Efficient Funding of Chemotherapy) Special Arrangement 2024 (PB 31 of 2024), which is administered by the Department of Health, Disability and Ageing.
Key dates
- Registered: 29 May 2026
- In force from: 29 May 2026
- Repealed on: 7 September 2026
What changed
The source document does not specify what changes were made to the underlying funding rules. The full instrument is available at legislation.gov.au/F2026L00649.
Key actions
- If your business supplies or dispenses chemotherapy drugs under the federal efficient funding arrangement, check the full instrument at legislation.gov.au/F2026L00649 to confirm what changed from 29 May 2026.
- Contact the Department of Health, Disability and Ageing directly for clarification on how the June 2026 amendments affect your arrangements before the instrument is repealed on 7 September 2026.
This is a plain-English summary for information only, not legal or compliance advice. Always check the official source or consult a qualified professional.